Novo Nordisk
NVO
NVO
491 hedge funds and large institutions have $7.6B invested in Novo Nordisk in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 141 increasing their positions, 187 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 484 → 491 (+7)
0.42% more ownership
Funds ownership: 15.67% → 16.09% (+0.42%)
25% less repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 187
Holders
491
Holding in Top 10
17
Calls
$30.4M
Puts
$18.3M
Top Buyers
| 1 | +$139M | |
| 2 | +$64.9M | |
| 3 | +$39.8M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$27.8M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$22.7M |
Top Sellers
| 1 | -$45.5M | |
| 2 | -$35.5M | |
| 3 | -$31.8M | |
| 4 |
SBAM
Santa Barbara Asset Management
Los Angeles,
California
|
-$15.9M |
| 5 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$12.2M |